oxidopamine has been researched along with Complex Regional Pain Syndromes in 2 studies
Oxidopamine: A neurotransmitter analogue that depletes noradrenergic stores in nerve endings and induces a reduction of dopamine levels in the brain. Its mechanism of action is related to the production of cytolytic free-radicals.
oxidopamine : A benzenetriol that is phenethylamine in which the hydrogens at positions 2, 4, and 5 on the phenyl ring are replaced by hydroxy groups. It occurs naturally in human urine, but is also produced as a metabolite of the drug DOPA (used for the treatment of Parkinson's disease).
Complex Regional Pain Syndromes: Conditions characterized by pain involving an extremity or other body region, HYPERESTHESIA, and localized autonomic dysfunction following injury to soft tissue or nerve. The pain is usually associated with ERYTHEMA; SKIN TEMPERATURE changes, abnormal sudomotor activity (i.e., changes in sweating due to altered sympathetic innervation) or edema. The degree of pain and other manifestations is out of proportion to that expected from the inciting event. Two subtypes of this condition have been described: type I; (REFLEX SYMPATHETIC DYSTROPHY) and type II; (CAUSALGIA). (From Pain 1995 Oct;63(1):127-33)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Sahbaie, P | 1 |
Li, WW | 1 |
Guo, TZ | 1 |
Shi, XY | 1 |
Kingery, WS | 2 |
Clark, JD | 2 |
Li, W | 1 |
Shi, X | 1 |
Wang, L | 1 |
Guo, T | 1 |
Wei, T | 1 |
Cheng, K | 1 |
Rice, KC | 1 |
2 other studies available for oxidopamine and Complex Regional Pain Syndromes
Article | Year |
---|---|
Autonomic Regulation of Nociceptive and Immunologic Changes in a Mouse Model of Complex Regional Pain Syndrome.
Topics: Animals; Autonomic Nervous System; Chronic Pain; Complex Regional Pain Syndromes; Disease Models, An | 2022 |
Epidermal adrenergic signaling contributes to inflammation and pain sensitization in a rat model of complex regional pain syndrome.
Topics: Adrenergic Agents; Animals; Bufanolides; Complex Regional Pain Syndromes; Disease Models, Animal; Do | 2013 |